This invention relates to novel compounds that are dihydroindoles derivatives and pharmaceutically acceptable salts thereof. More specifically, this invention relates to novel dihydroindoles derivatives that are derivatives of silodosin. This invention also provides compositions comprising one or more compounds of this invention and a carrier and the use of the disclosed compounds and compositions in methods of treating diseases and conditions that are beneficially treated by administering an α-1A-adrenoreceptor antagonist, such as silodosin.
本发明涉及一种新颖的化合物,它们是二氢
吲哚衍
生物及其药学上可接受的盐。更具体地说,本发明涉及一种新颖的二氢
吲哚衍
生物,它们是
硅唑洛辛的衍
生物。本发明还提供了包含本发明中的一种或多种化合物和载体的组合物,以及使用所披露的化合物和组合物治疗通过给予α-1A-
肾上腺素受体拮抗剂(如
硅唑洛辛)有益治疗的疾病和病状的方法。